Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125014462 | 12501446 | 2 | F | 2016 | 20160630 | 20160627 | 20160705 | EXP | CN-BAYER-2016-120324 | BAYER | 28.00 | YR | A | F | Y | 0.00000 | 20160705 | CN | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125014462 | 12501446 | 1 | PS | YASMIN | DROSPIRENONEETHINYL ESTRADIOL | 1 | Oral | UNK | 21098 | FILM-COATED TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125014462 | 12501446 | 1 | Endocrine disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125014462 | 12501446 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125014462 | 12501446 | Foetal growth restriction | |
| 125014462 | 12501446 | Maternal exposure before pregnancy | |
| 125014462 | 12501446 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125014462 | 12501446 | 1 | 201602 | 201604 | 0 |